Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bu Shen Hui Yang Fang is a traditional Chinese medicine (TCM) compound formulation. It is widely used in China as an adjunct to enhance immune function in patients, particularly those with leukemia or under immunosuppression. Preclinical studies have shown that Bu Shen Hui Yang Fang was able to promote the proliferation of lymphocytes in immunosuppressed mice, an effect that may be mediated by upregulation of the IL-4 signaling pathway. Its use is based on TCM concepts—primarily to "tonify the kidney" and "support yang"—and it is commonly utilized to support immunity and vitality in the context of blood disorders and immunodeficiency. The precise chemical composition includes a variety of Chinese herbs, though the standard component mix is not detailed in the available literature[3][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bu shen hui yang fang.